Cognis Report issue

For profit Phase 2
Founded: Monheim Germany (1999)
Status: Acquired by BASF (2010) → now IG Farben (1925)

Organization Overview

First Clinical Trial
2002
NCT00617617
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Cognis Deutschland GmbH & Co. KG | Natural Inc./Cognis GmbH | Natural Inc./Cognis GmbH (Dusseldorf, Germany)

Active Ingredients

Drugs in Phase 2 Trials (1)

prevastein hc (1 trial)

Drugs in Other Trials (4)

conjugated linoleic acid (2 trials)

olive (1 trial)

safflower oil (1 trial)

xanthophyll (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 5